During a roughly five-year span, CVS Health, Cigna, and UnitedHealth benefited the most from increasing prices for generic drugs that treated illnesses such as HIV and cancer. Some of the price hikes ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

President-elect Donald Trump has not backed down from insisting that the United States needs to acquire Greenland, a Danish ...

President-elect Trump’s threat to tariff Denmark if it resists his acquisition plans for the island territory of Greenland ...

Ozempic, a medication used to treat type 2 diabetes, has been prescribed to over 100,000 people in Denmark alone. Earlier this year, an American study raised concerns about its potential link to ...

The research, out of the University of Southern Denmark, builds on work from the U.S. published ... a new drug has been on the market for a few years, as is the case with Ozempic. It should be ...

Two large studies from the University of Southern Denmark (SDU) suggest that people with type 2 diabetes who use the drug Ozempic may face a higher risk of severe eye damage. Specifically ...

According to its website, Novo Nordisk was founded in 1923 in Copenhagen, Denmark’s capital city. It is best known for manufacturing diabetes medications, including Ozempic and Ozempic’s other ...

According to its website, Novo Nordisk was founded in 1923 in Copenhagen, Denmark’s capital city. It is best known for manufacturing diabetes medications, including Ozempic and Wegovy. Ozempic is used ...

Shares in Novo Nordisk have fallen by more than a quarter after the Ozempic maker revealed a set ... which is equivalent to nearly a quarter of Denmark’s GDP. Investors took fright after a ...

Denmark, France, Germany, Norway and the United States, rose by 42 per cent in the first nine months of the year. Sales of Ozempic - an injectable anti-diabetic treatment which has become popular ...

Diabetes patients using Ozempic were found to be over twice as ... according to researchers who analyzed years of patient data from Denmark and Norway.